Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

TCT 2021 | Increasing awareness of TA-TMA and therapeutic approaches

Transplant-associated thrombotic microangiopathy (TA-TMA) is an endothelial damage syndrome that is increasingly identified as a complication of autologous and allogeneic hematopoietic cell transplantation in adults and children. In this interview, Sergio A. Giralt, MD, PhD, Memorial Sloan-Kettering Cancer Center, New York, NY, discusses advances in TA-TMA awareness and treatment approaches for this transplant complication. This interview took place during the Transplantation & Cellular Therapy (TCT) 2021 Meetings.